El Salvador vs Trinidad and Tobago: Statin use vs. average non-HDL cholesterol levels
El Salvador
3.5
in 2018
Trinidad and Tobago
3.5
in 2018
El Salvador rank
52nd
Trinidad and Tobago rank
52nd
Statin use vs. average non-HDL cholesterol levels over time
- El Salvador
- Trinidad and Tobago
How they compare
El Salvador currently reports 3.5 against 3.5 in Trinidad and Tobago, a difference of 0.
The two have swapped places 2 times across 39 shared years of data; in 1980 it was Trinidad and Tobago ahead.
El Salvador ranks 52nd and Trinidad and Tobago ranks 52nd of 191 countries.
Across the 4 decades both report, El Salvador averaged higher in 3 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | El Salvador | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.48 | 3.5 | 0.02 | Trinidad and Tobago |
| 1990s | 3.66 | 3.47 | 0.19 | El Salvador |
| 2000s | 3.7 | 3.42 | 0.28 | El Salvador |
| 2010s | 3.59 | 3.5 | 0.0889 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, El Salvador or Trinidad and Tobago?
- El Salvador, at 3.5 against 3.5 in Trinidad and Tobago as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between El Salvador and Trinidad and Tobago?
- 0, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Trinidad and Tobago?
- 39 years are reported by both, from 1980 to 2018.
- How do El Salvador and Trinidad and Tobago rank globally for statin use vs. average non-hdl cholesterol levels?
- El Salvador ranks 52nd and Trinidad and Tobago ranks 52nd of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.